Nvidia-backed Iambic Therapeutics files for US IPO
Reuters reports that the drug developer, also backed by Qatar's sovereign wealth fund, is adding to a busy fall slate of biotech listings.
TLDR
Iambic Therapeutics filed for a US initial public offering on September 21, 2026, Reuters reports. The drug developer is backed by Nvidia and Qatar's sovereign wealth fund. Reuters describes the filing as adding to a busy slate of biotech listings this fall.
Combined views
113.1K
3 Sources, first seen 9d ago
24 likes7 comments9 saves4 reposts